These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2600939)

  • 41. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity.
    Haga HJ; Brun JG; Berntzen HB; Cervera R; Khamashta M; Hughes GR
    Lupus; 1993 Feb; 2(1):47-50. PubMed ID: 8485559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis.
    Berner Berntzen H; Endresen GK; Fagerhol MK; Spiechowicz J; Mowinckel P
    Scand J Clin Lab Invest; 1991 Nov; 51(7):643-50. PubMed ID: 1810024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis.
    Hammer HB; Kvien TK; Glennås A; Melby K
    Clin Exp Rheumatol; 1995; 13(1):59-64. PubMed ID: 7774104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concordant message of different inflammatory markers in patients with rheumatoid arthritis.
    Arvidsson NG; Gudbjörnsson B; Hällgren R; Larsson A
    Ups J Med Sci; 1998; 103(1):35-42. PubMed ID: 9789970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple intra-articular treatment of rheumatoid arthritis: a randomized prospective study comparing rifamycin SV with pefloxacin.
    Caruso I; Boccassini L; Cazzola M; Santandrea S; Montrone F; Dell'Acqua D; Salvaggio A
    J Int Med Res; 1992 Feb; 20(1):27-39. PubMed ID: 1568518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease.
    Thompson S; Kelly CA; Griffiths ID; Turner GA
    Clin Chim Acta; 1989 Oct; 184(3):251-8. PubMed ID: 2611998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of tests used to monitor rheumatoid arthritis.
    Bull BS; Westengard JC; Farr M; Bacon PA; Meyer PJ; Stuart J
    Lancet; 1989 Oct; 2(8669):965-7. PubMed ID: 2571873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate.
    Poole AR; Witter J; Roberts N; Piccolo F; Brandt R; Paquin J; Baron M
    Arthritis Rheum; 1990 Jun; 33(6):790-9. PubMed ID: 2141981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyridinium crosslinks excretion in patients with rheumatoid arthritis. Correlation with disease activity and glucocorticoid treatment.
    Xuereb Anastasi A; Buhagiar A; Camilleri F; Cauchi M; Mallia C
    Adv Exp Med Biol; 1999; 455():227-33. PubMed ID: 10599348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors related to the progression of joint destruction in rheumatoid arthritis.
    Sjöblom KG; Saxne T; Pettersson H; Wollheim FA
    Scand J Rheumatol; 1984; 13(1):21-7. PubMed ID: 6719058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on orosomucoid and haptoglobin in rheumatoid arthritis.
    NETTELBLADT E; SUNDBLAD L
    Acta Rheumatol Scand; 1961; 7():35-7. PubMed ID: 13728446
    [No Abstract]   [Full Text] [Related]  

  • 52. [Biochemical criteria of the activity of osteoarticular tuberculosis].
    Titarenko OT; Sadovoĭ MS; Perova TL; Sovetova NA; Esmedliaeva DS
    Probl Tuberk; 1990; (5):56-60. PubMed ID: 2388895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombocytosis in active rheumatoid arthritis. Relation to other parameters of inflammatory activity and confounding effect of automated cell counting.
    Dahlqvist SR; Nilsson TK; Norberg B
    Clin Rheumatol; 1988 Sep; 7(3):335-41. PubMed ID: 3229078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low serum calprotectin levels correlate with the presence of biological drugs after the first year of treatment in patients with rheumatoid arthritis.
    Martínez-Feito A; Plasencia-Rodríguez C; Navarro-Compán V; Jochems A; Hernández-Breijo B; Peiteado D; Tornero C; Pascual-Salcedo D; Balsa A
    Scand J Clin Lab Invest; 2019 Nov; 79(7):538-540. PubMed ID: 31561717
    [No Abstract]   [Full Text] [Related]  

  • 55. Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis.
    Wollheim FA; Pettersson H; Saxne T; Sjöblom KG
    Scand J Rheumatol; 1988; 17(6):445-53. PubMed ID: 3266030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels.
    Wollheim FA; Hanson A; Laurell CB
    Scand J Rheumatol; 1978; 7(3):171-6. PubMed ID: 364636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-reactive protein in femoral head necrosis.
    Gadsbøll N; Høilund-Carlsen PF; Widding A
    J Trauma; 1985 Jun; 25(6):511-5. PubMed ID: 3874289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific plasma proteins as indices of inflammation during a modified fast in patients with rheumatoid arthritis.
    Sköldstam L; Jorfelt L; Lindell B; Mårtensson J
    Scand J Rheumatol; 1983; 12(2):161-5. PubMed ID: 6857174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between haemoglobin and the other clinical and laboratory parameters in rheumatoid arthritis.
    Grennan DM; Anderson JA; Kennedy AC; Mitchell W; Dick WC; Buchanan WW
    Curr Med Res Opin; 1975; 3(2):104-8. PubMed ID: 1139963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Leukocyte agglomeration as an activity criterion of inflammatory processes].
    Fischer H
    Z Gesamte Inn Med; 1977 Feb; 32(4):56-7. PubMed ID: 324154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.